Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MacroGenics Inc

+ Add to Watchlist

MGNX:US

27.1700 USD 2.5600 8.61%

As of 20:10:00 ET on 05/05/2015.

Snapshot for MacroGenics Inc (MGNX)

Open: 29.4500 Day's Range: 26.6810 - 29.4500 Volume: 310,809
Previous Close: 29.7300 52wk Range: 17.3100 - 39.9000 1-Yr Rtn: +38.34%

Stock Chart for MGNX

No chart data available.
  • MGNX:US 27.1700
  • 1D
  • 1M
  • 1Y
29.7300
Interactive MGNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MGNX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.4000
Est. EPS (USD) (12/2015) -0.0050
Est. PEG Ratio -
Market Cap (M USD) 815.74
Shares Outstanding (M) 30.02
30 Day Average Volume 184,367
Price/Book (mrq) 6.2715
Price/Sale (ttm) 15.5016
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MGNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MGNX

MacroGenics, Inc. develops novel biologics. The Company specializes in treatments for autoimmune disorders, cancer, and infectious diseases. MacroGenics serves the healthcare industry in the United States.

Scott KoenigPresident/CEO/Co-FounderJames Karrels "Jim"Senior VP/CFO/Secretary
Atul SaranSenior VP/General CounselJon WiggintonSenior VP:Clinical Dev/Mng Dir
More Company Profile & Key Executives for MGNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil